MedTrace Logo

OASIS: RetrOspective Analysis on EEGs for Identifying Seizure Susceptibility in paediatrIcs Using biomarkerS

NCT06546410 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 530

Last updated 2026-07-30

No results posted yet for this study

Summary

The goal of this retrospective study is to validate a set of computational biomarkers (BioEP) for seizure susceptibility on retrospective routinely collected non-contributory EEGs in paediatric participants with epilepsy. The main objectives are:

Primary:

To validate a set of computational biomarkers (BioEP) for seizure susceptibility on retrospective routinely collected non-contributory EEGs in paediatric participants with epilepsy.

Secondary:

To examine whether the use of BioEP could support a more efficient patient pathway to diagnosis (thus adding economic value), by reducing time to final diagnosis and/or the number of clinical appointments needed

Conditions

Interventions

DEVICE

BioEP

All patient's EEG will have the BioEP score conducted on it

Sponsors & Collaborators

  • Neuronostics Ltd

    lead INDUSTRY

Principal Investigators

  • Wessel Woldman · Neuronostics Ltd

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2026-01-19
Completion
2026-01-19

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06546410 on ClinicalTrials.gov